DCT and neoplasm: Immunization with liposome-encapsulated TRP2 peptide which were then mixed with CpG ODN caused complete tumor rejection in only 20% of vaccinated mice [3]; VM, on the other hand, caused tumor rejection in all treated mice when two antigens were targeted.